Adverse events of a third dose of BNT162b2 mRNA COVID-19 vaccine among Korean healthcare workers
Due to the urgency of controlling the coronavirus disease 2019 pandemic, coronavirus disease 2019 messenger ribonucleic acid (mRNA) vaccines have been expeditiously approved and introduced in several countries without sufficient evaluation for adverse events. We analyzed adverse events among Korean...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10018524/ https://www.ncbi.nlm.nih.gov/pubmed/36930126 http://dx.doi.org/10.1097/MD.0000000000033236 |